epigallocatechin gallate has been researched along with Edema, Pulmonary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bo, L; Dong, M; Jin, F; Li, C; Li, Z; Liu, Q; Liu, W | 1 |
1 other study(ies) available for epigallocatechin gallate and Edema, Pulmonary
| Article | Year |
|---|---|
Epigallocatechin-3-gallate suppresses alveolar epithelial cell apoptosis in seawater aspiration-induced acute lung injury via inhibiting STAT1-caspase-3/p21 associated pathway.
Topics: Acute Lung Injury; Alveolar Epithelial Cells; Animals; Apoptosis; Caspase 3; Catechin; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Humans; Lung; Male; Phosphorylation; Pulmonary Edema; Rats, Sprague-Dawley; Respiratory Aspiration; Seawater; Signal Transduction; STAT1 Transcription Factor | 2016 |